XML 43 R34.htm IDEA: XBRL DOCUMENT
v3.22.2

Acquisitions (Narrative) (Details) $ / shares in Units, $ in Millions | 1 Months Ended | 3 Months Ended | 6 Months Ended
--- | --- | --- | ---
Jan. 31, 2021 USD ($) right $ / shares | Jun. 30, 2022 USD ($) | Jun. 30, 2021 USD ($) | Jun. 30, 2022 USD ($) | Jun. 30, 2021 USD ($)
Business Acquisition [Line Items] |  |  |  |  |
Acquired in-process research and development and development milestones |  | $ 440.4 | $ 42.8 | $ 606.0 | $ 354.8
Cash paid, net of cash acquired |  |  |  | $ 0.0 | $ 747.4
Acquired IPR&D Expense |  | $ 333.8 |  |  |
Prevail Therapeutics Inc. |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |
Business acquisition, share price (in dollars per share) | $ / shares | $ 22.50 |  |  |  |
Cash paid, net of cash acquired | $ 747.4 |  |  |  |
Consideration transferred, number of contingent value rights | right | 1 |  |  |  |
Contingent value right, additional price per share (up to) (in dollars per share) | $ / shares | $ 4.00 |  |  |  |
Contingent value right, additional price per share, aggregate amount | $ 160.0 |  |  |  |
Contingent value right, monthly reduction (in cents per share) | $ / shares | $ 0.083 |  |  |  |

X
- Definition Acquired In-Process Research And Development And Development Milestones + References No definition available. + Details
Name: | lly_AcquiredInProcessResearchAndDevelopmentAndDevelopmentMilestones
Namespace Prefix: | lly_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Business Acquisition, Contingent Value Right, Additional Price Per Share + References No definition available. + Details
Name: | lly_BusinessAcquisitionContingentValueRightAdditionalPricePerShare
Namespace Prefix: | lly_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Business Acquisition, Contingent Value Right, Covenant, Regulatory Approval Occurs + References No definition available. + Details
Name: | lly_BusinessAcquisitionContingentValueRightRegulatoryApprovalDelayMonthlyReduction
Namespace Prefix: | lly_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Business Combination, Consideration Transferred, Number Of Contingent Value Rights + References No definition available. + Details
Name: | lly_BusinessCombinationConsiderationTransferredNumberOfContingentValueRights
Namespace Prefix: | lly_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Payments for Asset Acquisitions + References No definition available. + Details
Name: | lly_PaymentsForAssetAcquisitions
Namespace Prefix: | lly_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_BusinessAcquisitionLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination. + References No definition available. + Details
Name: | us-gaap_BusinessAcquisitionSharePrice
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (c)(3) -URI https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479 + Details
Name: | us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585 + Details
Name: | us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=lly_PrevailTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |